Atlas Trials

Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder

Clinical trial NCT00143091 · TERMINATED

Trial details

NCT number
NCT00143091
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Depressive Disorder, Major
Start date
2005-04-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.